Botox Maker Settles Case
Wednesday, September 1, 2010 - 12:28
in Mathematics & Economics
Allergan agreed to pay $600 million to settle criminal and civil allegations that it had marketed Botox for medical uses, like pain and headache, not approved by the Food and Drug Administration.